Sunday, 19 July 2020

Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Special https://ift.tt/3jjsiDu
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US Moves To End 60-Day Grace Period For H-1B, Other Work Visa Holders

Under the planned rule change, published in the Federal Register by the US Department of Homeland Security, those with H-1B and certain othe...